QuTEM Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 30

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 7

  • Investments
  • 1

QuTEM General Information

Description

Developer of transmission electron microscopy services intended to support nanoparticle analysis and quality control in regulated environments. The company offers advanced imaging instruments, proprietary image analysis software, and validated analytical methodologies, enabling research organizations and industrial clients to obtain reliable data for material characterization.

Contact Information

Website
www.qutem.com
Formerly Known As
Vironova BioAnalytics
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly PE-Backed
Corporate Office
  • Gävlegatan 22
  • 113 30 Stockholm
  • Sweden
Primary Industry
Biotechnology
Other Industries
Other Commercial Services
Corporate Office
  • Gävlegatan 22
  • 113 30 Stockholm
  • Sweden

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

QuTEM Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore QuTEM‘s full profile, request access.

Request a free trial

QuTEM Patents

QuTEM Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2014140321-A1 Antiviral indolo[2,3-b]quinoxaline Inactive 15-Mar-2013
WO-2013171334-A1 Methanethione compounds having antiviral activity Inactive 18-May-2012
US-20150320746-A1 Pharmaceutical formulation comprising 2,3-dimethyl-6-(n,n-dimethylaminoethyl)-6h-indolo-(2,3-b)quinoxaline Active 18-Feb-2011
US-9789107-B2 Pharmaceutical formulation comprising 2,3-dimethyl-6-(n,n-dimethylaminoethyl)-6h-indolo-(2,3-b)quinoxaline Inactive 18-Feb-2011
US-20130310392-A1 Pharmaceutical formulation for topical administration comprising b220 Active 18-Feb-2011 A61K31/4985
To view QuTEM’s complete patent history, request access »

QuTEM Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

QuTEM Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore QuTEM‘s full profile, request access.

Request a free trial

QuTEM Investments (1)

QuTEM’s most recent deal was a Buyout/LBO with NOW Electronics (Sweden). The deal was made on 16-Dec-2015.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
NOW Electronics (Sweden) 16-Dec-2015 Buyout/LBO IT Consulting and Outsourcing
To view QuTEM’s complete investments history, request access »

QuTEM Exits (1)

QuTEM’s most recent exit was on 16-Dec-2015 from NOW Electronics (Sweden). The exit was categorized as with 2 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
NOW Electronics (Sweden) 16-Dec-2015 Completed
  • 2 buyers
To view QuTEM’s complete exits history, request access »

QuTEM FAQs

  • When was QuTEM founded?

    QuTEM was founded in 2005.

  • Where is QuTEM headquartered?

    QuTEM is headquartered in Stockholm, Sweden.

  • What is the size of QuTEM?

    QuTEM has 30 total employees.

  • What industry is QuTEM in?

    QuTEM’s primary industry is Biotechnology.

  • Is QuTEM a private or public company?

    QuTEM is a Private company.

  • What is QuTEM’s current revenue?

    The current revenue for QuTEM is .

  • How much funding has QuTEM raised over time?

    QuTEM has raised $30.7M.

  • Who are QuTEM’s investors?

    Flerie, Karolina Ventures, Katalysen Ventures, and Riyadh Valley Company have invested in QuTEM.

  • When was QuTEM acquired?

    QuTEM was acquired on 20-Nov-2023.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process